MPI Research – “Responsive CRO” Branding Initiative
MPI Research, the largest single-site preclinical contract research organisation in the world, today announced its global initiative to brand the company as "Your Responsive CRO".
MPI Research, the largest single-site preclinical contract research organisation in the world, today announced its global initiative to brand the company as "Your Responsive CRO".
MPI Research, the largest single-site preclinical contract research organisation in the world, has formed a collaboration with Andrew Hendrickx, PhD, a recognised expert in nonhuman primate developmental and reproductive toxicology (DART). As a consultant for the MPI Research nonhuman primate reproduction program, Dr Hendrickx will coach, guide, and participate in the study design and interpretation process.
On 26 January 2010, the Food and Drug Administration (FDA) released a key draft guidance document, Guidance for Industry Assessment of Abuse Potential of Drugs. When finalised, this guidance will represent the FDA's current position on the abuse potential of drugs.
On 8 April 2010 Biopartners GmbH announced that it had received EU marketing authorisation from the European Commission for Ribavirin Biopartners 200mg film-coated tablets. The product is intended for the treatment of chronic hepatitis C infection as part of a combination regimen with peginterferon alfa-2b interferon alfa-2b.
NDA, the leading European regulatory affairs consulting group, appoints Dr Panos Tsintis to its expanding panel of experts - the NDA Advisory Board.
Benzbromaron is one of the main uricosuric drugs currently used. In addition to sophisticated and expensive LC-MS and GC-MS methods, benzbromaron can be effectively determined by titration with sodium hydroxide solution using straightforward, fully automated sample preparation. For the latter, the 815 Robotic Soliprep is the perfect instrument.
No other industry is as thoroughly regulated as the pharmaceutical industry. The active ingredients are legion and so are the standards to test for them. Metrohm's new brochure "Pharmaceutical analysis" is a highly valuable compendium that gives an overall view of the most important parameters determining the quality of pharmaceuticals and the methods best suited to check them.
Secure shipping service for international companies expanding in Russia.
Innovaro, a comprehensive innovation solution company, is pleased to announce the formation of Verdant Ventures Advisors, LLC, an independently managed technology transfer venture fund.
UTEK Corporation, a leading IP licensing and innovation services company, is pleased to announce a partnership between MEDEC and MedilinkUK and its online licensing marketplaces, Pharmalicensing and Medical Device Licensing. Through this partnership, hundreds of new companies can take advantage of UTEK’s growing network of registered companies and industry professionals, all looking to identify licensing and partnering opportunities worldwide.